| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 611,096,084.45 | 3,044,752,019.57 | 2,221,298,453.24 | 1,424,058,255.02 |
| 收到的税费返还 | 1,477,166.24 | 21,666,783.71 | 17,715,833.32 | 12,863,838.46 |
| 收到其他与经营活动有关的现金 | 17,609,041.13 | 280,899,136.13 | 162,353,243.36 | 23,476,161.47 |
| 经营活动现金流入小计 | 630,182,291.82 | 3,347,317,939.41 | 2,401,367,529.92 | 1,460,398,254.95 |
| 购买商品、接受劳务支付的现金 | 386,506,251.2 | 1,667,015,404.88 | 1,268,190,701.62 | 860,163,071.6 |
| 支付给职工以及为职工支付的现金 | 133,884,974.69 | 449,919,089.29 | 344,598,761.37 | 242,373,010.94 |
| 支付的各项税费 | 47,108,857.22 | 180,439,343.05 | 126,925,957.45 | 100,041,394.11 |
| 支付其他与经营活动有关的现金 | 66,670,221.6 | 659,761,235.65 | 422,352,488.76 | 170,088,868.36 |
| 经营活动现金流出小计 | 634,170,304.71 | 2,957,135,072.87 | 2,162,067,909.2 | 1,372,666,345.01 |
| 经营活动产生的现金流量净额 | -3,988,012.89 | 390,182,866.54 | 239,299,620.72 | 87,731,909.94 |
| 二、投资活动产生的现金流量: | | | | |
| 取得投资收益收到的现金 | 3,619,993.91 | 25,709,314.06 | 19,863,051.72 | 14,065,404.95 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 232,743.36 | 535,025.98 | 437,946.91 | 437,946.91 |
| 收到的其他与投资活动有关的现金 | 268,779,202.72 | 2,074,730,592.47 | 1,835,014,120 | 1,340,014,120 |
| 投资活动现金流入小计 | 272,631,939.99 | 2,100,974,932.51 | 1,855,315,118.63 | 1,354,517,471.86 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 1,010,048.92 | 8,337,976.54 | 6,192,920.67 | 3,944,392.53 |
| 支付其他与投资活动有关的现金 | 359,743,180.55 | 2,183,000,000 | 1,875,000,000 | 1,232,000,000 |
| 投资活动现金流出小计 | 360,753,229.47 | 2,191,337,976.54 | 1,881,192,920.67 | 1,235,944,392.53 |
| 投资活动产生的现金流量净额 | -88,121,289.48 | -90,363,044.03 | -25,877,802.04 | 118,573,079.33 |
| 三、筹资活动产生的现金流量: | | | | |
| 取得借款收到的现金 | - | 1,491,000 | 1,491,000 | 1,491,000 |
| 收到其他与筹资活动有关的现金 | - | - | 0 | - |
| 筹资活动现金流入平衡项目 | - | 0 | 0 | 0 |
| 筹资活动现金流入小计 | - | 1,491,000 | 1,491,000 | 1,491,000 |
| 偿还债务支付的现金 | 317,631 | 1,517,964.88 | 1,119,181 | 699,553 |
| 分配股利、利润或偿付利息支付的现金 | 21,013,943.5 | 227,289,633.57 | 226,046,943.86 | 221,030,014.16 |
| 其中:子公司支付给少数股东的股利、利润 | 21,000,000 | 6,227,408 | 5,000,000 | - |
| 支付其他与筹资活动有关的现金 | 883,508.15 | 4,612,691.33 | 3,649,903.2 | 2,187,039.8 |
| 筹资活动现金流出小计 | 22,215,082.65 | 233,420,289.78 | 230,816,028.06 | 223,916,606.96 |
| 筹资活动产生的现金流量净额 | -22,215,082.65 | -231,929,289.78 | -229,325,028.06 | -222,425,606.96 |
| 四、汇率变动对现金及现金等价物的影响 | -1,971,632.23 | 1,894,502.17 | 3,580,443.55 | 4,693,772.62 |
| 五、现金及现金等价物净增加额 | -116,296,017.25 | 69,785,034.9 | -12,322,765.83 | -11,426,845.07 |
| 加:期初现金及现金等价物余额 | 410,088,601.8 | 340,303,566.9 | 340,303,566.9 | 340,303,566.9 |
| 期末现金及现金等价物余额 | 293,792,584.55 | 410,088,601.8 | 327,980,801.07 | 328,876,721.83 |
| 补充资料: | | | | |
| 净利润 | - | 465,358,735.37 | - | 222,901,542.34 |
| 资产减值准备 | - | 7,709,287.36 | - | 3,016,862.85 |
| 固定资产和投资性房地产折旧 | - | 32,459,001.32 | - | 16,748,435.89 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 32,459,001.32 | - | 16,748,435.89 |
| 无形资产摊销 | - | 4,635,798.15 | - | 2,366,414.37 |
| 长期待摊费用摊销 | - | 2,684,207.71 | - | 1,288,605.47 |
| 处置固定资产、无形资产和其他长期资产的损失 | - | 12,229.89 | - | -63,658.2 |
| 固定资产报废损失 | - | 141,380.04 | - | 101,215.74 |
| 公允价值变动损失 | - | -21,871,937.86 | - | -11,259,484.7 |
| 财务费用 | - | -1,593,598.57 | - | -4,221,835.85 |
| 投资损失 | - | -12,516,375.78 | - | -5,608,526.02 |
| 递延所得税 | - | 6,646,482.23 | - | 723,408.9 |
| 其中:递延所得税资产减少 | - | 3,699,889.91 | - | 1,035,436.38 |
| 递延所得税负债增加 | - | 2,946,592.32 | - | -312,027.48 |
| 存货的减少 | - | 43,227,875.63 | - | 3,001,221.74 |
| 经营性应收项目的减少 | - | 69,097,634.31 | - | -20,135,820.93 |
| 经营性应付项目的增加 | - | -95,168,928.19 | - | -113,563,238.28 |
| 其他 | - | -112,587,167.97 | - | -9,819,146.23 |
| 现金的期末余额 | - | 410,088,601.8 | - | 328,876,721.83 |
| 减:现金的期初余额 | - | 340,303,566.9 | - | 340,303,566.9 |
| 现金及现金等价物的净增加额 | - | 69,785,034.9 | - | -11,426,845.07 |
| 公告日期 | 2026-04-24 | 2026-03-28 | 2025-10-31 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |